MODIFICATION
B -- Performance of companion diagnostics in real-world settings: Comparison of FDA-approved immunohistochemistry tests and fluorenscence in situ hybridization technology tests in predicting response to trastuzumab
- Notice Date
- 9/6/2011
- Notice Type
- Modification/Amendment
- NAICS
- 622110
— General Medical and Surgical Hospitals
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-RFQ-1090414
- Archive Date
- 9/23/2011
- Point of Contact
- Christopher E. Cunningham, Phone: 301-827-7185, Doreen Williams,
- E-Mail Address
-
christopher.cunningham@fda.hhs.gov, doreen.williams@fda.hhs.gov
(christopher.cunningham@fda.hhs.gov, doreen.williams@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Please see the attachment for complete combined synopsis/solicitation in MS Word. THIS NOTICE HAS BEEN EXTENDED UNTIL 9/8/2011
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-RFQ-1090414/listing.html)
- Record
- SN02563180-W 20110908/110906235145-4ae945dad2aa0a075ba85b5ab1f95120 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |